Answers are grounded in this paper and cite their sources.
Prospective validation reveals AI predicts glioblastoma infiltration, suggesting improvements for treatment planning.
To our knowledge, this study provides the first prospective, biopsy-controlled, molecular validation of an AI model for mapping glioblastoma infiltration. By accurately identifying histologically and transcriptionally infiltrated regions, GlioMap offers a biologically grounded imaging biomarker that could guide extended resection and personalised radiotherapy planning, potentially improving tumour control and patient outcomes.
No takes yet. Share an insight, caveat, or question.
Cepeda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: